CTSO vs WY · rev $18.5M vs P/E 43, rev $3.59B
Cytosorbents Crp (CTSO) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
CTSO currently screens at market cap $28.8M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the CTSO and WY stock pages for the full models.
Not investment advice.